Centrexion stock hits 52-week low at $0.9 amid market challenges
In a challenging market environment, Centrexion Therapeutics Corp stock has touched a 52-week low, with shares falling to $0.9. According to InvestingPro data, the stock shows significant volatility ...
Japan Pharmaceutical Manufacturing Market to Worth Over USD 62.0 Billion By 2033 | Astute Analytica
Japan’s market growth accelerates through dynamic clinical partnerships, biologic breakthroughs, and automated facilities.
MM&M5h
TikTok is back — for now. What does it mean for medical marketing?
Medical marketing leaders weigh in on the temporary respite for TikTok and what it means for pharma clients. After a ...
Piper Sandler Issues a Buy Rating on Karyopharm Therapeutics (KPTI)
Piper Sandler analyst Christopher Raymond assigned a Buy rating to Karyopharm Therapeutics (KPTI – Research Report) today and set a price ...
Piper Sandler Remains a Buy on Regeneron (REGN)
Piper Sandler analyst Christopher Raymond maintained a Buy rating on Regeneron (REGN – Research Report) today and set a price target of ...
Pharmaceutical Technology11h
Amgen opens new drug substance facility in North Carolina, US
Amgen has inaugurated its new drug substance facility in the US after announcing a $1bn further expansion at the North ...